Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6847 | 1437 | 36.4 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
29 | 3 | HIV//VIROLOGY//HIV 1 | 108954 |
2828 | 2 | HIV ASSOCIATED NEPHROPATHY//TENOFOVIR//HIVAN | 2999 |
6847 | 1 | HIV ASSOCIATED NEPHROPATHY//TENOFOVIR//HIVAN | 1437 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HIV ASSOCIATED NEPHROPATHY | authKW | 1067893 | 5% | 74% | 68 |
2 | TENOFOVIR | authKW | 958440 | 13% | 24% | 187 |
3 | HIVAN | authKW | 368276 | 2% | 67% | 26 |
4 | HIV NEPHROPATHY | authKW | 245853 | 1% | 64% | 18 |
5 | TENOFOVIR ALAFENAMIDE | authKW | 244969 | 1% | 82% | 14 |
6 | HIV ASSOCIATED NEPHROPATHY HIVAN | authKW | 193159 | 1% | 91% | 10 |
7 | INDINAVIR | authKW | 127068 | 3% | 14% | 43 |
8 | HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED NEPHROPATHY | authKW | 114730 | 1% | 60% | 9 |
9 | TENOFOVIR DISOPROXIL FUMARATE | authKW | 93455 | 2% | 20% | 22 |
10 | AIDS ASSOCIATED NEPHROPATHY | authKW | 84987 | 0% | 67% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 22028 | 36% | 0% | 520 |
2 | Infectious Diseases | 16965 | 32% | 0% | 467 |
3 | Virology | 3546 | 12% | 0% | 177 |
4 | Immunology | 2678 | 22% | 0% | 314 |
5 | Medicine, General & Internal | 555 | 11% | 0% | 152 |
6 | Transplantation | 535 | 4% | 0% | 63 |
7 | Pharmacology & Pharmacy | 466 | 13% | 0% | 185 |
8 | Microbiology | 402 | 8% | 0% | 120 |
9 | Pediatrics | 89 | 4% | 0% | 54 |
10 | Pathology | 57 | 3% | 0% | 36 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN INFECT DIS HOSP HYG | 67991 | 0% | 80% | 4 |
2 | INFECT DIS IMMUNOPATHOL UNIT | 63743 | 0% | 100% | 3 |
3 | COMMUNITY CARE | 60693 | 1% | 29% | 10 |
4 | HOSP ST JAUME DE OLOT | 47806 | 0% | 75% | 3 |
5 | UGC INFECT DIS | 42495 | 0% | 100% | 2 |
6 | INTERNAL MED CLIN IMMUNOL UNIT | 38243 | 0% | 60% | 3 |
7 | NEPHROL | 35535 | 23% | 1% | 326 |
8 | RENAL SCI | 29503 | 0% | 28% | 5 |
9 | AIDS CLIN | 26033 | 1% | 6% | 20 |
10 | ACUTE DIALYSIS SERV | 21248 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AIDS | 21275 | 6% | 1% | 93 |
2 | HIV MEDICINE | 15214 | 2% | 3% | 28 |
3 | AMERICAN JOURNAL OF KIDNEY DISEASES | 9899 | 4% | 1% | 63 |
4 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 9258 | 3% | 1% | 43 |
5 | KIDNEY INTERNATIONAL | 6308 | 5% | 0% | 66 |
6 | CLINICAL NEPHROLOGY | 5847 | 3% | 1% | 37 |
7 | ANTIVIRAL THERAPY | 5456 | 2% | 1% | 22 |
8 | ADVANCES IN CHRONIC KIDNEY DISEASE | 4713 | 1% | 2% | 12 |
9 | AIDS PATIENT CARE AND STDS | 4634 | 1% | 1% | 19 |
10 | SEMINARS IN NEPHROLOGY | 4399 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV ASSOCIATED NEPHROPATHY | 1067893 | 5% | 74% | 68 | Search HIV+ASSOCIATED+NEPHROPATHY | Search HIV+ASSOCIATED+NEPHROPATHY |
2 | TENOFOVIR | 958440 | 13% | 24% | 187 | Search TENOFOVIR | Search TENOFOVIR |
3 | HIVAN | 368276 | 2% | 67% | 26 | Search HIVAN | Search HIVAN |
4 | HIV NEPHROPATHY | 245853 | 1% | 64% | 18 | Search HIV+NEPHROPATHY | Search HIV+NEPHROPATHY |
5 | TENOFOVIR ALAFENAMIDE | 244969 | 1% | 82% | 14 | Search TENOFOVIR+ALAFENAMIDE | Search TENOFOVIR+ALAFENAMIDE |
6 | HIV ASSOCIATED NEPHROPATHY HIVAN | 193159 | 1% | 91% | 10 | Search HIV+ASSOCIATED+NEPHROPATHY+HIVAN | Search HIV+ASSOCIATED+NEPHROPATHY+HIVAN |
7 | INDINAVIR | 127068 | 3% | 14% | 43 | Search INDINAVIR | Search INDINAVIR |
8 | HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED NEPHROPATHY | 114730 | 1% | 60% | 9 | Search HUMAN+IMMUNODEFICIENCY+VIRUS+ASSOCIATED+NEPHROPATHY | Search HUMAN+IMMUNODEFICIENCY+VIRUS+ASSOCIATED+NEPHROPATHY |
9 | TENOFOVIR DISOPROXIL FUMARATE | 93455 | 2% | 20% | 22 | Search TENOFOVIR+DISOPROXIL+FUMARATE | Search TENOFOVIR+DISOPROXIL+FUMARATE |
10 | AIDS ASSOCIATED NEPHROPATHY | 84987 | 0% | 67% | 6 | Search AIDS+ASSOCIATED+NEPHROPATHY | Search AIDS+ASSOCIATED+NEPHROPATHY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LUCAS, GM , ROSS, MJ , STOCK, PG , SHLIPAK, MG , WYATT, CM , GUPTA, SK , ATTA, MG , WOOLS-KALOUSTIAN, KK , PHAM, PA , BRUGGEMAN, LA , ET AL (2014) CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS INFECTED WITH HIV: 2014 UPDATE BY THE HIV MEDICINE ASSOCIATION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA.CLINICAL INFECTIOUS DISEASES. VOL. 59. ISSUE 9. P. E96 -E138 | 161 | 45% | 32 |
2 | ROSENBERG, AZ , NAICKER, S , WINKLER, CA , KOPP, JB , (2015) HIV-ASSOCIATED NEPHROPATHIES: EPIDEMIOLOGY, PATHOLOGY, MECHANISMS AND TREATMENT.NATURE REVIEWS NEPHROLOGY. VOL. 11. ISSUE 3. P. 150 -160 | 86 | 72% | 13 |
3 | GUPTA, SK , EUSTACE, JA , WINSTON, JA , BOYDSTUN, II , AHUJA, TS , RODRIGUEZ, RA , TASHIMA, KT , ROLAND, M , FRANCESCHINI, N , PALELLA, FJ , ET AL (2005) GUIDELINES FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE IN HIV-INFECTED PATIENTS: RECOMMENDATIONS OF THE HIV MEDICINE ASSOCIATION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA.CLINICAL INFECTIOUS DISEASES. VOL. 40. ISSUE 11. P. 1559 -1585 | 99 | 60% | 348 |
4 | HALL, AM , (2013) UPDATE ON TENOFOVIR TOXICITY IN THE KIDNEY.PEDIATRIC NEPHROLOGY. VOL. 28. ISSUE 7. P. 1011 -1023 | 74 | 76% | 24 |
5 | FINE, DM , PERAZELLA, MA , LUCAS, GM , ATTA, MG , (2008) RENAL DISEASE IN PATIENTS WITH HIV INFECTION - EPIDEMIOLOGY, PATHOGENESIS AND MANAGEMENT.DRUGS. VOL. 68. ISSUE 7. P. 963-980 | 90 | 71% | 41 |
6 | YOMBI, JC , JONES, R , POZNIAK, A , HOUGARDY, JM , POST, FA , (2015) MONITORING OF KIDNEY FUNCTION IN HIV-POSITIVE PATIENTS.HIV MEDICINE. VOL. 16. ISSUE 8. P. 457 -467 | 66 | 86% | 2 |
7 | CALZA, L , (2012) RENAL TOXICITY ASSOCIATED WITH ANTIRETROVIRAL THERAPY.HIV CLINICAL TRIALS. VOL. 13. ISSUE 4. P. 189 -211 | 70 | 79% | 23 |
8 | MAGGI, P , BARTOLOZZI, D , BONFANTI, P , CALZA, L , CHERUBINI, C , DI BIAGIO, A , MARCOTULLIO, S , MONTELLA, F , MONTINARO, V , MUSSINI, C , ET AL (2012) RENAL COMPLICATIONS IN HIV DISEASE: BETWEEN PRESENT AND FUTURE.AIDS REVIEWS. VOL. 14. ISSUE 1. P. 37-53 | 79 | 71% | 15 |
9 | BHIMMA, R , PURSWANI, MU , KALA, U , (2013) KIDNEY DISEASE IN CHILDREN AND ADOLESCENTS WITH PERINATAL HIV-1 INFECTION.JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. VOL. 16. ISSUE . P. - | 87 | 62% | 11 |
10 | DE SILVA, TI , POST, FA , GRIFFIN, MD , DOCKRELL, DH , (2007) HIV-1 INFECTION AND THE KIDNEY: AN EVOLVING CHALLENGE IN HIV MEDICINE.MAYO CLINIC PROCEEDINGS. VOL. 82. ISSUE 9. P. 1103-1116 | 109 | 55% | 26 |
Classes with closest relation at Level 1 |